Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Japanese researchers describe amidine compounds for eating disorders

Jan. 29, 1999

Nippon Soda discloses new series of inhibitors of cholesterol biosynthesis

Jan. 29, 1999

Another lipid-lowering statin now on the market in Argentina

Jan. 28, 1999

SB patents new cathepsin K inhibitors

Jan. 28, 1999

Widely used herbal antiobesity agent tested in randomized, controlled trial

Jan. 27, 1999

Another market introduction for Lilly's SERM

Jan. 27, 1999

Livial not available in Germany for osteoporosis prevention

Jan. 27, 1999

Potent ACAT inhibitors for lipid disorders from Sankyo

Jan. 27, 1999

Amylin reports additional data from long-term pramlintide studies

Jan. 27, 1999

Japanese authorities approve Viagra

Jan. 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 6, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads
BioWorld
Novartis AG is to pay $1.1 billion up front to acquire Myricx Bio Ltd., a preclinical-stage antibody-drug conjugate (ADC) specialist that is advancing a novel and...